Literature DB >> 23180898

Preparation of H,(4) PyrrolidineQuin-BAM (PBAM).

Tyler A Davis, Mark C Dobish, Kenneth E Schwieter, Aspen C Chun, Jeffrey N Johnston.   

Abstract

Entities:  

Year:  2012        PMID： 23180898      PMCID： PMC3505069          DOI： 10.15227/orgsyn.089.0380

Source DB:  PubMed          Journal:  Organic Synth        ISSN： 0078-6209


× No keyword cloud information.
  14 in total

1.  Chiral proton catalysis: enantioselective Brønsted acid catalyzed additions of nitroacetic acid derivatives as glycine equivalents.

Authors:  Anand Singh; Ryan A Yoder; Bo Shen; Jeffrey N Johnston
Journal:  J Am Chem Soc       Date:  2007-03-07       Impact factor: 15.419

2.  A diastereo- and enantioselective synthesis of alpha-substituted anti-alpha,beta-diaminophosphonic acid derivatives.

Authors:  Jeremy C Wilt; Maren Pink; Jeffrey N Johnston
Journal:  Chem Commun (Camb)       Date:  2008-08-06       Impact factor: 6.222

3.  Discovery of competing anaerobic and aerobic pathways in umpolung amide synthesis allows for site-selective amide 18O-labeling.

Authors:  Jessica P Shackleford; Bo Shen; Jeffrey N Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-19       Impact factor: 11.205

4.  Demethylation of 2,4-dimethoxyquinolines: the synthesis of atanine.

Authors:  Keith Jones; Xavier Roset; Sharon Rossiter; Philip Whitfield
Journal:  Org Biomol Chem       Date:  2003-11-06       Impact factor: 3.876

5.  Catalytic Enantioselective Addition of Nitro Compounds to Imines-A Simple Approach for the Synthesis of Optically Active β-Nitro-α-Amino Esters.

Authors:  N Nishiwaki; K Rahbek Knudsen; K V Gothelf; K A Jørgensen
Journal:  Angew Chem Int Ed Engl       Date:  2001       Impact factor: 15.336

6.  Umpolung reactivity in amide and peptide synthesis.

Authors:  Bo Shen; Dawn M Makley; Jeffrey N Johnston
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

7.  A formal enantioselective acetate Mannich reaction: the nitro functional group as a traceless agent for activation and enantiocontrol in the synthesis of beta-amino acids.

Authors:  Bo Shen; Jeffrey N Johnston
Journal:  Org Lett       Date:  2008-09-18       Impact factor: 6.005

8.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

9.  Chiral proton catalysis: a catalytic enantioselective direct aza-Henry reaction.

Authors:  Benjamin M Nugent; Ryan A Yoder; Jeffrey N Johnston
Journal:  J Am Chem Soc       Date:  2004-03-24       Impact factor: 15.419

10.  Brønsted-acid-catalyzed activation of nitroalkanes: a direct enantioselective aza-Henry reaction.

Authors:  Magnus Rueping; Andrey P Antonchick
Journal:  Org Lett       Date:  2008-04-08       Impact factor: 6.005
View more
  10 in total

1.  Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale.

Authors:  Tyler A Davis; Anna E Vilgelm; Ann Richmond; Jeffrey N Johnston
Journal:  J Org Chem       Date:  2013-10-15       Impact factor: 4.354

2.  Achiral counterion control of enantioselectivity in a Brønsted acid-catalyzed iodolactonization.

Authors:  Mark C Dobish; Jeffrey N Johnston
Journal:  J Am Chem Soc       Date:  2012-03-30       Impact factor: 15.419

3.  Chiral proton catalysis of secondary nitroalkane additions to azomethine: synthesis of a potent GlyT1 inhibitor.

Authors:  Tyler A Davis; Michael W Danneman; Jeffrey N Johnston
Journal:  Chem Commun (Camb)       Date:  2012-04-30       Impact factor: 6.222

4.  Enantioselective Synthesis of α-Bromonitroalkanes for Umpolung Amide Synthesis: Preparation of tert-Butyl ((1R)-1-(4-(benzyloxy)phenyl)-2-bromo-2-nitroethyl)carbamate.

Authors:  Victoria T Lim; Sergey V Tsukanov; Amanda B Stephens; Jeffrey N Johnston
Journal:  Organic Synth       Date:  2016

5.  Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.

Authors:  Mark C Dobish; Fernando Villalta; Michael R Waterman; Galina I Lepesheva; Jeffrey N Johnston
Journal:  Org Lett       Date:  2012-12-07       Impact factor: 6.005

6.  Development of an Intermittent-Flow Enantioselective Aza-Henry Reaction Using an Arylnitromethane and Homogeneous Brønsted Acid-Base Catalyst with Recycle.

Authors:  Sergey V Tsukanov; Martin D Johnson; Scott A May; Morgan Rosemeyer; Michael A Watkins; Stanley P Kolis; Matthew H Yates; Jeffrey N Johnston
Journal:  Org Process Res Dev       Date:  2016-02-01       Impact factor: 3.317

7.  Organocatalytic, diastereo- and enantioselective synthesis of nonsymmetric cis-stilbene diamines: a platform for the preparation of single-enantiomer cis-imidazolines for protein-protein inhibition.

Authors:  Brandon A Vara; Anand Mayasundari; John C Tellis; Michael W Danneman; Vanessa Arredondo; Tyler A Davis; Jaeki Min; Kristin Finch; R Kiplin Guy; Jeffrey N Johnston
Journal:  J Org Chem       Date:  2014-07-14       Impact factor: 4.354

8.  Adaptation of a small-molecule hydrogen-bond donor catalyst to an enantioselective hetero-Diels-Alder reaction hypothesized for brevianamide biosynthesis.

Authors:  Daniel J Sprague; Benjamin M Nugent; Ryan A Yoder; Brandon A Vara; Jeffrey N Johnston
Journal:  Org Lett       Date:  2015-01-31       Impact factor: 6.005

9.  Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking.

Authors:  Carine Santos; Luiz Pimentel; Henayle Canzian; Andressa Oliveira; Floriano Junior; Rafael Dantas; Lucas Hoelz; Debora Marinho; Anna Cunha; Monica Bastos; Nubia Boechat
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-03

10.  Diastereo- and enantioselective additions of α-nitro esters to imines for anti-α,β-diamino acid synthesis with α-alkyl-substitution.

Authors:  Daniel J Sprague; Anand Singh; Jeffrey N Johnston
Journal:  Chem Sci       Date:  2018-01-31       Impact factor: 9.825
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.